000 -LEADER |
fixed length control field |
03922nam a22004455i 4500 |
001 - CONTROL NUMBER |
control field |
978-1-59745-047-8 |
003 - CONTROL NUMBER IDENTIFIER |
control field |
DE-He213 |
005 - DATE AND TIME OF LATEST TRANSACTION |
control field |
20161121230638.0 |
007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION |
fixed length control field |
cr nn 008mamaa |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
fixed length control field |
100301s2006 xxu| s |||| 0|eng d |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
International Standard Book Number |
9781597450478 |
-- |
978-1-59745-047-8 |
024 7# - OTHER STANDARD IDENTIFIER |
Standard number or code |
10.1007/978-1-59745-047-8 |
Source of number or code |
doi |
050 #4 - LIBRARY OF CONGRESS CALL NUMBER |
Classification number |
RE1-994 |
072 #7 - SUBJECT CATEGORY CODE |
Subject category code |
MJQ |
Source |
bicssc |
072 #7 - SUBJECT CATEGORY CODE |
Subject category code |
MED063000 |
Source |
bisacsh |
082 04 - DEWEY DECIMAL CLASSIFICATION NUMBER |
Classification number |
617.7 |
Edition number |
23 |
245 10 - TITLE STATEMENT |
Title |
Ocular Angiogenesis |
Medium |
[electronic resource] : |
Remainder of title |
Diseases, Mechanisms, and Therapeutics / |
Statement of responsibility, etc. |
edited by Joyce Tombrain-Tink, Colin J. Barnstable. |
264 #1 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE |
Place of production, publication, distribution, manufacture |
Totowa, NJ : |
Name of producer, publisher, distributor, manufacturer |
Humana Press, |
Date of production, publication, distribution, manufacture, or copyright notice |
2006. |
300 ## - PHYSICAL DESCRIPTION |
Other physical details |
online resource. |
336 ## - CONTENT TYPE |
Content type term |
text |
Content type code |
txt |
Source |
rdacontent |
337 ## - MEDIA TYPE |
Media type term |
computer |
Media type code |
c |
Source |
rdamedia |
338 ## - CARRIER TYPE |
Carrier type term |
online resource |
Carrier type code |
cr |
Source |
rdacarrier |
347 ## - DIGITAL FILE CHARACTERISTICS |
File type |
text file |
Encoding format |
PDF |
Source |
rda |
490 1# - SERIES STATEMENT |
Series statement |
Opthalmology Research |
505 0# - FORMATTED CONTENTS NOTE |
Formatted contents note |
Angiogenic Diseases -- Age-Related Macular Degeneration -- Endogenous Angiogenic Inhibitors in Diabetic Retinopathy -- Corneal Angiogenesis -- Polypoidal Choroidal Vasculopathy -- Myopic Choroidal Neovascularization -- Mechanisms of the Formation and Stability of Retinal Blood Vessels -- Neovascular Glaucoma -- Eales’ Disease -- Angiogenesis and Ocular Tumorigenesis -- Genetics of Ocular Vascular Disease -- Endogenous Promoters and Inhibitors of Angiogenesis -- Vascular Endothelial Growth Factor and Retinal Diseases -- The Role of Fibroblast Growth Factors in Ocular Angiogenesis -- Control of Neovascularization and Cell Survival in the Eye by PEDF -- Thrombospondin -- Regulation of Ocular Angiogenesis by Matrix Proteases and Tissue Inhibitors of Metalloproteinases -- Integrins in Ocular Angiogenesis -- Ocular Inflammation and Neovascularization -- Therapeutics and Delivery for Angiogenic eye Diseases -- Anti-VEGF Therapies for Diseases of the Retina and Choroid -- Anecortave Acetate -- Gene Therapy for Neovascular Retinopathies -- Noninvasive Delivery of DNA Into the Eye -- Novel Drug Delivery Systems for Posterior Segment Ocular Disease. |
520 ## - SUMMARY, ETC. |
Summary, etc. |
The recent intense study of pathogenic ocular angiogenesis-an abnormal growth of blood vessels in the eye responsible for the major blinding diseases throughout the world-has yielded an overwhelming flood of scientific findings, novel insights, and possible future therapeutic approaches. In Ocular Angiogenesis: Diseases, Mechanisms, and Therapeutics, leading academic and pharmaceutical researchers and clinicians from many disciplines synthesize and summarize these developments to present a comprehensive review of what is known about angiogenesis, its role in blinding diseases, and the mechanisms leading to progressive vessel dysfunction. The authors also identify and assess the most promising approaches with potential for commercial exploitation and discuss the challenges encountered in developing therapeutics for ocular neovascular diseases. Highlights include illuminating chapters on gene therapy and novel drug delivery systems and excellent summaries of the newest therapeutic approaches. Comprehensive and multidisciplinary, Ocular Angiogenesis: Diseases, Mechanisms, and Therapeutics offers a novel view of the clinical features of pathological angiogenesis in the eye, the molecular and environmental switches that govern vessel growth, and the tremendous opportunities for and progress made in the development of new therapeutics. |
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
Medicine. |
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
Ophthalmology. |
650 14 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
Medicine & Public Health. |
650 24 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
Ophthalmology. |
700 1# - ADDED ENTRY--PERSONAL NAME |
Personal name |
Tombrain-Tink, Joyce. |
Relator term |
editor. |
700 1# - ADDED ENTRY--PERSONAL NAME |
Personal name |
Barnstable, Colin J. |
Relator term |
editor. |
710 2# - ADDED ENTRY--CORPORATE NAME |
Corporate name or jurisdiction name as entry element |
SpringerLink (Online service) |
773 0# - HOST ITEM ENTRY |
Title |
Springer eBooks |
776 08 - ADDITIONAL PHYSICAL FORM ENTRY |
Relationship information |
Printed edition: |
International Standard Book Number |
9781588295149 |
830 #0 - SERIES ADDED ENTRY--UNIFORM TITLE |
Uniform title |
Opthalmology Research |
856 40 - ELECTRONIC LOCATION AND ACCESS |
Uniform Resource Identifier |
http://dx.doi.org/10.1007/978-1-59745-047-8 |
912 ## - |
-- |
ZDB-2-SME |